Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500097500Phase 4Not yet recruiting
Phase 4, randomised trial in colorectal cancer (CRC) comparing Hydrocodone IV analgesia with Sufentanil IV analgesia (2 arms). Primary endpoint: Quality of recovery (QoR-15 score). Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500097500.